|
Apr 18
|
Wall Street Trims Ratings for Novo Nordisk Stock, as Ozempic’s Competition Grows
|
|
Apr 18
|
Eli Lilly Vows to Make Weight-Loss Pill in U.S. as Trump Pushes for Domestic Manufacturing
|
|
Apr 18
|
Eli Lilly jumps as results from weight-loss pill study rival competitor’s
|
|
Apr 17
|
How Eli Lilly's GLP-1 pill could transform the weight-loss space
|
|
Apr 17
|
Eli Lilly Rockets 14% After Solidifying Its Lead For A Weight-Loss Pill
|
|
Apr 17
|
Novo Nordisk downgraded by BMO as Eli Lilly gains ground in weight-loss drug race
|
|
Apr 17
|
Novo Nordisk Stock Drops on Eli Lilly Oral Weight-Loss Drug Success, Downgrade
|
|
Apr 17
|
Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide
|
|
Apr 17
|
Eli Lilly stock soars on positive weight-loss pill results
|
|
Apr 17
|
Novo Nordisk shares slump following Eli Lilly’s weight-loss pill success
|
|
Apr 17
|
Eli Lilly's Mounjaro Launch Triggers Weight-Loss Drug Craze In India, Novo Nordisk Seeks To Move Up Wegovy Launch
|
|
Apr 17
|
“I Am a Buyer”: Jim Cramer Backs Novo Nordisk (NVO) After Its Sharp Decline
|
|
Apr 16
|
The GLP-1 drug shortage is over. What’s next for the compounders?
|
|
Apr 16
|
Eli Lilly Stock Down 8.2% in a Month: Should You Buy the Dip?
|
|
Apr 15
|
Counterfeit Ozempic Identified in US Supply Chain With Fake Labels And Needles, FDA Alerts
|
|
Apr 15
|
Is Novo Nordisk A/S (NVO) the Best Pharma Stock to Buy for Long Term Growth?
|
|
Apr 15
|
Pfizer Halts Obesity Pill Development Amid Safety Concerns
|
|
Apr 15
|
Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill
|
|
Apr 15
|
NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback
|
|
Mar 13
|
Novo Nordisk (NVO) Gains As Market Dips: What You Should Know
|